The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions
BMC Infectious Diseases2012Vol. 12(1), pp. 131–131
Citations Over TimeTop 10% of 2012 papers
Abstract
HBeAg estimates are crucial for understanding the epidemiology of HBV and for prioritizing implementation of WHO`s prevention recommendations for all infants to receive the first dose of hepatitis B vaccine within 24 hours of birth. Results will have importance as access to treatment for chronic HBV infection is expanded.
Related Papers
- → Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus infection among students in Ahmadu Bello University, Zaria, Nigeria(2017)7 cited
- → Evaluation of a New Rapid Test for the Combined Detection of Hepatitis B Virus Surface Antigen and Hepatitis B Virus e Antigen(2002)34 cited
- → Seroepidemiological study of hepatitis B virus markers in Japan(2015)13 cited
- A study on hepatitis B virus transmission from father to infant(2011)
- DETECT AND ANALYSIS ON HEPATITIS B MARKERS IN SERUM(2011)